NIH #5R01CA299421-02
Improving Management of patients at High Risk of Pancreatic Cancer
- Amount
- $649K
- Period
- 2025-02-24 → 2030-01-31
- PIs
- 2
- Est. capacity / PI
- ~3 students
Cancer Genomics and Diagnostics · Cancer Research
17 total · 7 active
NIH #5R01CA299421-02
NIH #1R01CA299421-01
NIH #5P50CA228991-07
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
2026-06-18
2026-06-18
2026-06-18
2026-06-18
2026-06-18
2026-06-18
2026-06-18
2026-06-18
2026-06-18
2026-06-18
2026-06-18
2026-06-18
2026-06-18
2026-06-18
2026-06-18
Lethal toxin–equipped effector cells for the potential treatment of cancer
Proceedings of the National Academy of Sciences · 2026-03-16
TRBC2-targeting antibody–drug conjugates for the treatment of T cell cancers
Nature Cancer · 2025-12-22 · 2 citations
Integrated Spatial Analysis Reveals the Molecular Landscape of Ovarian Precancerous Lesions
Cancer Research · 2025-12-18 · 1 citations
2025-12-12
2025-12-12